Diabetes, Digestive, and Kidney Diseases Extramural Research in Nebraska
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $14.9 million to recipients in Nebraska in 11 grants from fiscal 2021 to 2025, 0.2% of the program's national total. Board of Regents of the University of Nebraska received the most, $9.8 million.
- Awarded in Nebraska$14.9 million
- Awards11
- Share of the program0.2%
- Rank among states38th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 9 | $3.8 million |
| FY 2022 | 8 | $3.5 million |
| FY 2023 | 7 | $3.4 million |
| FY 2024 | 6 | $2.5 million |
| FY 2025 | 3 | $1.7 million |
Recipients in Nebraska
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Board of Regents of the University of Nebraska | Colleges and universities | 7 | $9.8 million |
| Board of Regents of the University of Nebraska | Colleges and universities | 3 | $4.1 million |
| Creighton University | Colleges and universities | 1 | $1.0 million |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Nebraska?
$14.9 million from fiscal 2021 to 2025, across 11 awards. Nebraska ranks 38th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Nebraska?
The largest recipient is Board of Regents of the University of Nebraska, with $9.8 million in 7 awards. Next are Board of Regents of the University of Nebraska and Creighton University.
Can organizations in Nebraska apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Nebraska
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Special Education Grants to States
- Broadband Equity, Access, and Deployment Program
- Greenhouse Gas Reduction Fund: Clean Communities Investment Accelerator